Jefferies Group LLC Eli Lilly & CO Call Options Transaction History

Jefferies Group LLC

$10.2 Billion
Q3 2022

Call Options

21 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2022 Sep 21, 2023	BUY	$296.48 - $337.87 $12.1 Million - $13.8 Million	40,900 Added 163.6%	65,900 $21.3 Million
Q3 2022 Nov 14, 2022	BUY	$296.48 - $337.87 $12.1 Million - $13.8 Million	40,900 Added 163.6%	65,900 $21.3 Million
Q1 2022 Sep 21, 2023	BUY	$234.69 - $291.66 $2.96 Million - $3.67 Million	12,600 Added 101.61%	25,000 $7.16 Million
Q1 2022 May 16, 2022	BUY	$234.69 - $291.66 $2.96 Million - $3.67 Million	12,600 Added 101.61%	25,000 $7.16 Million
Q4 2021 Sep 21, 2023	BUY	$224.85 - $279.04 $1.21 Million - $1.51 Million	5,400 Added 77.14%	12,400 $3.43 Million
Q4 2021 Feb 14, 2022	BUY	$224.85 - $279.04 $1.21 Million - $1.51 Million	5,400 Added 77.14%	12,400 $3.43 Million
Q2 2021 Sep 21, 2023	SELL	$180.55 - $233.54 $10.6 Million - $13.8 Million	-58,900 Reduced 89.38%	7,000 $1.61 Million
Q2 2021 Aug 20, 2021	SELL	$180.55 - $233.54 $125 Million - $162 Million	-693,000 Reduced 99.0%	7,000 $1.61 Million
Q2 2021 Aug 16, 2021	BUY	$180.55 - $233.54 $121 Million - $156 Million	670,000 Added 2233.33%	700,000 $1.61 Million
Q2 2020 Aug 14, 2020	SELL	$136.42 - $164.18 $272,840 - $328,360	-2,000 Reduced 6.25%	30,000 $4.93 Million
Q1 2020 May 15, 2020	SELL	$119.05 - $147.35 $6.11 Million - $7.56 Million	-51,300 Reduced 61.58%	32,000 $4.44 Million
Q4 2019 Feb 13, 2020	BUY	$106.92 - $132.43 $7.08 Million - $8.77 Million	66,200 Added 387.13%	83,300 $10.9 Million
Q3 2019 Nov 13, 2019	SELL	$106.79 - $116.16 $1.71 Million - $1.86 Million	-16,000 Reduced 48.34%	17,100 $1.91 Million
Q2 2019 Aug 14, 2019	SELL	$110.79 - $129.32 $4.1 Million - $4.78 Million	-37,000 Reduced 52.78%	33,100 $3.67 Million
Q1 2019 May 15, 2019	BUY	$111.31 - $131.02 $5.19 Million - $6.11 Million	46,600 Added 198.3%	70,100 $9.1 Million
Q4 2018 Feb 14, 2019	SELL	$105.9 - $118.64 $5.8 Million - $6.5 Million	-54,800 Reduced 69.99%	23,500 $2.72 Million
Q3 2018 Nov 14, 2018	SELL	$85.86 - $107.31 $3.25 Million - $4.07 Million	-37,900 Reduced 32.62%	78,300 $8.4 Million
Q2 2018 Aug 14, 2018	BUY	$75.7 - $86.88 $5.69 Million - $6.53 Million	75,200 Added 183.41%	116,200 $9.92 Million
Q1 2018 May 15, 2018	SELL	$74.21 - $87.6 $5.4 Million - $6.38 Million	-72,800 Reduced 63.97%	41,000 $3.17 Million
Q4 2017 Feb 14, 2018	SELL	$81.94 - $87.89 $1.7 Million - $1.83 Million	-20,800 Reduced 15.45%	113,800 $9.61 Million
Q3 2017 Nov 14, 2017	BUY	$77.07 - $85.54 $10.4 Million - $11.5 Million	134,600	134,600 $11.5 Million

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

Lilly Endowment Inc Indianapolis, IN

96.9M
Shares

$74.4 Billion
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

73.8M
Shares

$56.6 Billion
1.2% of portfolio
Black Rock Inc. New York, NY

65.9M
Shares

$50.6 Billion
1.37% of portfolio
Pnc Financial Services Group, Inc. Pittsburgh, PA

51.4M
Shares

$39.4 Billion
29.2% of portfolio
State Street Corp Boston, MA

33.9M
Shares

$26 Billion
1.24% of portfolio

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $730B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jefferies Group LLC with notifications on news.

Account